US 10342791
Regimens of tafenoquine for prevention of malaria in malaria-naive subjects
granted A61KA61K31/4706A61P
Quick answer
US patent 10342791 (Regimens of tafenoquine for prevention of malaria in malaria-naive subjects) held by The United States of America as represented by the Secretary of the Army expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K31/4706, A61P, A61P33/06